Biopharmaceuticals
Oncology
FDA
News Release - July 7, 2010
Genentech Submits Application to FDA for Trastuzumab-DM1 in Previously Treated Advanced HER2-Positive Breast Cancer
Source: Genentech
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.